Homologous recombination (상동재조합, HR) is a type of genetic recombination in which nucleotide sequences are exchanged between two similar or identical molecules of DNA. (https://en.wikipedia.org/wiki/Homologous_recombination)

HR을 통해 DNA의 double strand break repair를 할 수 있는데, BRCA1, BRCA2가 기능을 못하면 이것이 어려워지고, Mutational signature 3 형태의 돌연변이가 많아짐.

Incoming Links #

Related Medical Scholarly Articles (MedicalScholarlyArticle 0) #

• Biomarkers in triple negative breast cancer: A review
• CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
• Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
• Mechanisms underlying mutational signatures in human cancers

Related Drug Classes (DrugClass 1) #

• PARP inhibitor

Related Articles (Article 2) #

• BRCA1
• DNA repair
• Homologous recombination deficiency
• Mutational signature

Suggested Pages #

• 0.373 Synthetic lethality
• 0.065 CDK12
• 0.036 Non-homologous end joining
• 0.028 MutaGene
• 0.025 1994
• 0.025 Journal of Clinical Oncology
• 0.025 Base exision repair
• 0.024 Addenbrooke's Hospital
• 0.023 Nucleotide excision repair
• 0.023 Nature Communications
• More suggestions...